Condition
Adjuvant Treatment clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Adjuvant Treatment clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Switching aromatase inhibitors versus guideline-based side-effect care to help with AI side effects
This test tries switching one aromatase inhibitor to another versus using guideline-based side-effect care to see which helps postmenopausal women with early-stage ER-positive breast cancer stay on their hormone therapy.
-
Firmonertinib versus placebo as additional treatment after surgery for stage IB–IIIB non‑small cell lung cancer with uncommon EGFR mutations
This trial will test whether taking firmonertinib after complete lung cancer surgery helps prevent recurrence in people with stage IB–IIIB NSCLC that has uncommon EGFR mutations.
Related topics
Quick answers
How many Adjuvant Treatment clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.